David Miller, MD, MS

Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3699 - Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis

  Wednesday, October 2, 2024
  10:30 AM – 11:45 AM ET